1. Draft guidance/Guidance for Industry. Drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations;U.S. Department of Health and Human Services,2012
2. Guideline on the investigation of drug interactions;European Medicines Agency,2013
3. Guideline on drug interaction for drug development and appropriate provision of information (final draft),2014
4. Evaluation of cytochrome P450-mediated drug–drug interactions based on the strategies recommended by regulatory authorities;Kosugi;Xenobiotica,2012
5. Drug–drug interaction studies: regulatory guidance and an industry perspective;Prueksaritanont;AAPS J,2013